Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-019394
Filing Date
2010-03-31
Accepted
2010-03-31 09:24:47
Documents
1
Period of Report
2010-03-29

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c98596_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c98596_4x0.xml 4 3999
  Complete submission text file 0001209191-10-019394.txt   5895
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
HENNEY CHRISTOPHER S (Reporting) CIK: 0001242880 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 10716653